In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
News|Slideshows|May 23, 2024
Slideshow: Mental Health Burden of Food Allergy, Nutritional Intervention May Help Children
Author(s)Killian Meara
Recent research on food allergy highlights the mental health concerns of people living with a food allergy, how nutritional intervention can help children with food allergy, and that peanut introduction can reduce rates of new allergy in high-risk infants.
Advertisement
In the United States, around 6.2% of adults reported having a food allergy and 5.8% of children have one.1 According to the American College of Allergy, Asthma and Immunology, 90% of all food allergies are caused by 8 types of food, including eggs, dairy, peanuts, fish, shellfish, and wheat.2 Food Allergy represents a significant public health concern, which is why it’s critical to understand how food allergy impacts the quality of life of patients and ways to manage it.
References
1. More Than a Quarter of U.S. Adults and Children Have at Least One Allergy. News Release. CDC. January 26, 2023. Accessed May 23, 2024. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220126.htm
2. Food Allergy Overview. Report. American College of Allergy, Asthma and Immunology. Accessed May 23, 2024. https://acaai.org/allergies/allergic-conditions/food/
3. Casale TB, Warren C, Gupta S, et al. The mental health burden of food allergies: Insights from patients and their caregivers from the Food Allergy Research & Education (FARE) Patient Registry. World Allergy Organ J. 2024;17(4):100891. Published 2024 Mar 23. doi:10.1016/j.waojou.2024.100891
4. Venter C, Meyer R, Bauer M, et al. Identifying Children at Risk of Growth and Nutrient Deficiencies in the Food Allergy Clinic. J Allergy Clin Immunol Pract. 2024;12(3):579-589. doi:10.1016/j.jaip.2024.01.027
5. Banerjee A, Wood R, Dunlop J, et al. Rates of New Peanut Allergy and Discontinuation Following Introduction in High-Risk Infants. J Allergy Clin Immunol Pract. 2024;12(3):645-651.e1. doi:10.1016/j.jaip.2023.11.035
Advertisement
Related to this article
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
Advertisement
Advertisement
Trending on Drug Topics
1
Polypharmacy, Drug Interactions Threaten Older Adults’ Medication Safety
2
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
3
Early CGMs Results in Better 5-Year Glucose Control in Type 1 Diabetes
4
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
5